» Authors » Marina Zemskova

Marina Zemskova

Explore the profile of Marina Zemskova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 806
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bird S, Gelperin K, Smith E, Jung T, Lyu H, Thompson A, et al.
Ann Intern Med . 2024 Nov; 178(1):29-38. PMID: 39556837
Background: There is a paucity of data on treatment of osteoporosis in patients with advanced chronic kidney disease (CKD). Objective: To assess the risk for emergently treated hypocalcemia with denosumab...
2.
Bird S, Smith E, Gelperin K, Jung T, Thompson A, Kambhampati R, et al.
JAMA . 2024 Jan; 331(6):491-499. PMID: 38241060
Importance: Dialysis-dependent patients experience high rates of morbidity from fractures, yet little evidence is available on optimal treatment strategies. Chronic kidney disease-mineral and bone disorder is nearly universal in dialysis-dependent...
3.
Luo H, Tobey A, Auh S, Cochran C, Behairy N, Merino M, et al.
Front Pharmacol . 2022 Oct; 13:791710. PMID: 36249761
A low-iodine diet (LID) of <50μ iodine/day is recommended as preparation for radioactive iodine (RAI) therapy in patients with differentiated thyroid cancer (DTC). The 24-h urinary iodine excretion (UIE) is...
4.
Lee R, Papa N, Introna M, Reese C, Zemskova M, Bonner M, et al.
J Scleroderma Relat Disord . 2022 Apr; 4(2):127-136. PMID: 35382388
The potential value of mesenchymal stromal/stem cell therapy in treating skin fibrosis in scleroderma (systemic sclerosis) and of the caveolin-1 scaffolding domain peptide in treating lung, skin, and heart fibrosis...
5.
James J, Zemskova M, Eccles C, Varghese M, Niihori M, Barker N, et al.
Arterioscler Thromb Vasc Biol . 2020 Dec; 41(2):734-754. PMID: 33297749
Objective: NFU1 is a mitochondrial iron-sulfur scaffold protein, involved in iron-sulfur assembly and transfer to complex II and LAS (lipoic acid synthase). Patients with the point mutation NFU1 and CRISPR/CAS9...
6.
Zemskova M, McClain N, Niihori M, Varghese M, James J, Rafikov R, et al.
Hypertension . 2020 Oct; 76(6):1787-1799. PMID: 33012199
Damage-associated molecular patterns, such as HMGB1 (high mobility group box 1), play a well-recognized role in the development of pulmonary arterial hypertension (PAH), a progressive fatal disease of the pulmonary...
7.
James J, Srivastava A, Valuparampil Varghese M, Eccles C, Zemskova M, Rafikova O, et al.
Blood . 2020 Jun; 136(6):749-754. PMID: 32548640
Several studies demonstrate that hemolysis and free heme in circulation cause endothelial barrier dysfunction and are associated with severe pathological conditions such as acute respiratory distress syndrome, acute chest syndrome,...
8.
Zemskova M, Kurdyukov S, James J, McClain N, Rafikov R, Rafikova O
PLoS One . 2020 Apr; 15(4):e0231267. PMID: 32271800
Women are known to be associated with a higher susceptibility to pulmonary arterial hypertension (PAH). In contrast, male PAH patients have a worse survival prognosis. In this study, we investigated...
9.
Gomes-Lima C, Auh S, Thakur S, Zemskova M, Cochran C, Merkel R, et al.
Front Endocrinol (Lausanne) . 2020 Mar; 11:53. PMID: 32132976
Thyroid ultrasound (US), fine needle aspiration biopsy (FNAB), and molecular testing have been widely used to stratify the risk of malignancy in thyroid nodules. The goal of this study was...
10.
Niihori M, Eccles C, Kurdyukov S, Zemskova M, Valuparampil Varghese M, Stepanova A, et al.
Am J Respir Cell Mol Biol . 2019 Aug; 62(2):231-242. PMID: 31461310
NFU1 is a mitochondrial protein that is involved in the biosynthesis of iron-sulfur clusters, and its genetic modification is associated with disorders of mitochondrial energy metabolism. Patients with autosomal-recessive inheritance...